Sun, MD
Chen Sun, Bethesda, MD US
Patent application number | Description | Published |
---|---|---|
20080269157 | Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations - Alterations in ERG gene expression can be observed in patients with prostate cancer. Specific ERG isoforms are associated with, or involved in, prostate cancer. Compositions comprising these isoforms provide therapeutic benefit and can be used in methods of detecting, diagnosing, prognosing, and treating prostate cancer. These compositions provide biomarkers for detecting the expression of combinations of the PSA/KLK3, PMEPA1, NKX3.1, ODC1, AMD1, and ERG genes. | 10-30-2008 |
20100144832 | Prostate Cancer-Specific Alternations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations - The disclosure describes alterations in ERG gene expression. ERG isoforms and promoter sequence of the ERG gene that are involved in, or associated with, prostate cancer are provided. The disclosure further provides therapeutic compositions and methods of detecting, diagnosing, prognosing, and treating prostate cancer, including biomarkers for detecting the expression of two or more of the following genes: PSA/KLK3, PMEPA1, NKX3.1, ODC1, AMD1, and ERG. | 06-10-2010 |
20150044670 | PROSTATE CANCER-SPECIFIC ALTERATIONS IN ERG GENE EXPRESSION AND DETECTION AND TREATMENT METHODS BASED ON THOSE ALTERATIONS - The disclosure describes alterations in ERG gene expression. ERG isoforms and promoter sequence of the ERG gene that are involved in, or associated with, prostate cancer are provided. The disclosure further provides therapeutic compositions and methods of detecting, diagnosing, prognosing, and treating prostate cancer, including biomarkers for detecting the expression of two or more of the following genes: PSA/KLK3, PMEPA1, NKX3.1, ODC1, AMD1, and ERG. | 02-12-2015 |
Feng Sun, Columbia, MD US
Patent application number | Description | Published |
---|---|---|
20120193041 | Multi-Display Dual-Function Shade for Glass Window/Door - A multi-display dual-function shade includes a piece of transparency printed with multiple displaying sections and two motors to roll the transparency onto two parallel rollers. The shade acts as a variable glowing display lit by daylight and provides privacy all the time. Multiple displaying sections provide various displaying effect and allow users to choose a desired amount of daylight through the shade anytime of a day or year. The printed transparency can be detached from one roller and completely rolled up onto the other roller to leave the glass window/door uncovered when needed. The multi-display dual-function shade allows easy insertion of new displaying sections into or replacement of the existing transparency to increase the displaying capacity. An integrated multi-display dual-function shade system can be made by installing the shade between the two panes of the glass window/door. An online server system can be set up to generate the customized shade. | 08-02-2012 |
Fengwen Sun, Germantown, MD US
Patent application number | Description | Published |
---|---|---|
20100316144 | EFFICIENT FRAMING SCHEMES FOR SUPPORTING VCM/ACM IN DIGITAL SATELLITE TRANSMISSION SYSTEMS - A digital communication system and method using a digital signal having a plurality of frames to transmit data, including a first frame and a second frame, wherein each of the plurality of frames has a frame structure; and wherein the first frame has, a plurality of codewords comprising user data, and a Next Frame Composition Table to set the structure for the second frame, and wherein the second frame has at least one codeword. | 12-16-2010 |
20110096718 | EFFICIENT FRAME STRUCTURE FOR DIGITAL SATELLITE COMMUNICATION - A digital communications system and method to transmit and receive a digital communications signal wherein the digital signal has a plurality of frames, wherein at least two modulations are supported, and wherein each of the plurality of frames has the same number of symbols. | 04-28-2011 |
20110107183 | INTERLEAVING SCHEME FOR AN LDPC CODED 16 APSK SYSTEM - An approach is provided for interleaving low density parity check (LDPC) encoded bits in 16ASPK modulation systems. By assigning the bits determining modulation symbols based on different bit degrees, one can efficiently find the desirable tradeoff between error performance and error floor provided by the LDPC codes in use. | 05-05-2011 |
20110164705 | BIT MAPPING SCHEME FOR AN LDPC CODED 32APSK SYSTEM - A digital communication system, having a transmitter to transmit a digital signal; and a receiver to receive the digital signal; wherein the digital signal utilizes a 32APSK system with FEC coding, and the signal is bit-mapped using gray mapping, and bits of the digital signal are ordered based on the values of a log likelihood ratio from a communications channel. | 07-07-2011 |
20110173509 | BIT MAPPING SCHEME FOR AN LDPC CODED 16APSK SYSTEM - A digital communication system, having a transmitter to transmit a digital signal; and a receiver to receive the digital signal; wherein the digital signal utilizes a 16APSK system, and the signal is bit-mapped using gray mapping, and bits of the digital signal are ordered based on the values of a log likelihood ratio from a communications channel. | 07-14-2011 |
20110202814 | INTERLEAVING SCHEME FOR AN LDPC CODED 32 APSK SYSTEM - An approach is provided for interleaving low density parity check (LDPC) encoded bits in 32APSK modulation systems. By assigning the bits determining modulation symbols based on different bit degrees, one can efficiently find the desirable tradeoff between error performance and error floor provided by the LDPC codes in use. | 08-18-2011 |
20110258521 | INTERLEAVING SCHEME FOR AN LDPC CODED QPSK/8PSK SYSTEM - An approach is provided for interleaving low density parity check (LDPC) encoded bits in QPSK/8PSK modulation systems. By assigning the bits determining modulation symbols based on different bit degrees, one can efficiently find the desirable tradeoff between error performance and error floor provided by the LDPC codes in use. | 10-20-2011 |
20110307754 | FAMILY OF LDPC CODES FOR VIDEO BROADCASTING APPLICATIONS - A family of quasi cyclic irregular low density parity check codes for video broadcasting applications. The parity check matrices of the constructed low density parity check codes have quasi-cyclic structures to facilitate hardware implementation and have proper check/bit degree distributions to offer frame error rate performance lower than 10 | 12-15-2011 |
Feng-Wen Sun, Germantow, MD US
Patent application number | Description | Published |
---|---|---|
20100005363 | CODE DESIGN AND IMPLEMENTATION IMPROVEMENTS FOR LOW DENSITY PARITY CHECK CODES FOR WIRELESS ROUTERS USING 802.11N PROTOCOL - Method and apparatus for implementing LDPC codes in an IEEE 802.11 standard system configured to operate in a Multiple-Input, Multiple-Output (MIMO) schema. A method in accordance with the present invention comprises defining a base LDPC code, having a length equal to an integer number of data carriers in an ODFM symbol, transmitting the base LDPC code over a plurality of sub-carriers, wherein the base code is transmitted at an expected phase on sub-carriers specified by the IEEE 802.11 standard system, and transmitting the base LDPC code on other sub-carriers than those specified by the IEEE 802.11 standard system, wherein the base LDPC code on the other sub-carriers is transmit offset in phase from the base LDPC code on the specified sub-carriers. | 01-07-2010 |
Guoming Sun, Lutherville, MD US
Patent application number | Description | Published |
---|---|---|
20120107369 | Polymers and Hydrogels - Methods and compositions related polymers and hydrogels. In some cases to biodegradable hydrogels for use in medical applications are disclosed. The polymers and hydrogels may be produced from cross-linked dextran and poly(epoxides). The poly(epoxides) may be poloxamers. | 05-03-2012 |
Guoming Sun, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20110275565 | BIOCOMPATIBLE POLYSACCHARIDE-BASED HYDROGELS - Modified polysaccharides and crosslinked modified polysaccharide compositions are described. Methods of using the crosslinked modified polysaccharide compositions to deliver proteins, oligonucleotides, or pharmaceutical agents are also disclosed. | 11-10-2011 |
20130102531 | FUNCTIONAL VASCULARIZATION WITH BIOCOMPATIBLE POLYSACCHARIDE-BASED HYDROGELS - Slow vascularization of functional blood limits the transplantation of tissue constructs and the recovery of ischemic and wounded tissues. Blood vessel ingrowth into polysaccharide-based hydrogel scaffolds remains a challenge. A synergistic effect of multiple angiogenic GFs was established; the co-encapsulation of VEGF plus other growth factors induced more and larger blood vessels than any individual GF, while the combination of all GFs dramatically increased the size and number of newly formed functional vessels. Rapid, efficient, and functional neovascularization may be achieved. | 04-25-2013 |
20150174154 | SKIN AND HAIR REGENERATION USING POLYSACCHARIDE-BASED HYDROGELS - Methods for promoting skin regeneration, promoting hair follicle regeneration, and reducing scarring by topically administering polysaccharide-based hydrogel compositions to injured skin are presented. | 06-25-2015 |
Haiyan Sun, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20100129854 | LIVER CELL TOXICITY ASSAY - The disclosure provides methods for characterizing the toxicity of a candidate molecule to liver cells as defined herein; methods of culturing metabolically active liver cells on a biosensor as defined herein; and biosensor liver culture systems as defined herein. | 05-27-2010 |
20110246078 | MITOCHONDRIA KATP ION CHANNEL AS A DRUG TARGET FOR PREVENTING LIVER DISEASES AND METHODS TO SCREEN MITOCHONDRIA KATP MODULATORS - Disclosed are compositions and methods related to modulation of K | 10-06-2011 |
20120022116 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL CONDITION(S) RELATED TO GPR35 AND/OR GPR35-HERG COMPLEX - Disclosed are compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically related to GPR35, and/or GPR35-hERG signaling complex. For example, disclosed are compounds for preventing and/or treating diseases which are pathophysiologically related to GPR35 in a subject. The compounds having a formula (I), (II) or (III): | 01-26-2012 |
Hongmao Sun, Germantown, MD US
Patent application number | Description | Published |
---|---|---|
20120184542 | PYRIDO PYRIMIDINES - Compounds of formula | 07-19-2012 |
Hui Sun, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20090029930 | Methods of gene therapy using nucleic acid sequences for ATP-binding cassette transporter - The present invention provides nucleic acid and amino acid sequences of an ATP binding cassette transporter and mutated sequences thereof associated with macular degeneration. Methods of detecting agents that modify ATP-binding cassette transporter comprising combining purified ATP binding cassette transporter and at least one agent suspected of modifying the ATP binding cassette transporter an observing a change in at least one characteristic associated with ATP binding cassette transporter. Methods of detecting macular degeneration is also embodied by the present invention. | 01-29-2009 |
20120040456 | METHODS OF GENE THERAPY USING NUCLEIC ACID SEQUENCES FOR ATP-BINDING CASSETTE TRANSPORTER - The present invention provides nucleic acid and amino acid sequences of an ATP binding cassette transporter and mutated sequences thereof associated with macular degeneration. Methods of detecting agents that modify ATP-binding cassette transporter comprising combining purified ATP binding cassette transporter and at least one agent suspected of modifying the ATP binding cassette transporter an observing a change in at least one characteristic associated with ATP binding cassette transporter. Methods of detecting macular degeneration is also embodied by the present invention. | 02-16-2012 |
Jason Sun, Columbia, MD US
Patent application number | Description | Published |
---|---|---|
20080297973 | Varactors including interconnect layers - In an embodiment of the present invention is provided a varactor comprising a substrate, a bottom electrode positioned on a surface of the substrate, a tunable dielectric material positioned adjacent to and extending over the bottom electrode forming a step and in contact with a top electrode, and an interconnect layer in contact with the bottom electrode, the tunable dielectric and the top electrode. | 12-04-2008 |
20090091000 | Varactores including interconnect layers - In an embodiment of the present invention is provided a varactor comprising a substrate, a plurality of bottom electrodes positioned on a surface of the substrate separated to form a gap therein, a tunable dielectric material positioned on the surface of the substrate and within the gap, the tunable dielectric at least partially overlaying the plurality of electrodes, and a top electrode in contact with the tunable dielectric. | 04-09-2009 |
20130320501 | VARACTORS INCLUDING INTERCONNECT LAYERS - In an embodiment of the present invention is provided a varactor comprising a substrate, a plurality of bottom electrodes positioned on a surface of the substrate separated to form a gap therein, a tunable dielectric material positioned on the surface of the substrate and within the gap, the tunable dielectric at least partially overlaying the plurality of electrodes, and a top electrode in contact with the tunable dielectric. | 12-05-2013 |
Jia Sun, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20100244001 | MEGAHERTZ ORGANIC/POLYMER DIODES AND METHODS RELATED THERETO - Featured is an organic/polymer diode having a first layer composed essentially of one of an organic semiconductor material or a polymeric semiconductor material and a second layer formed on the first layer and being electrically coupled to the first layer such that current flows through the layers in one direction when a voltage is applied in one direction. The second layer is essentially composed of a material whose characteristics and properties are such that when formed on the first layer, the diode is capable of high frequency rectifications on the order of megahertz rectifications such as for example rectifications at one of above 100 KHz, 500 KhZ, IMHz, or 10 MHz. In further embodiments, the layers are arranged so as to be exposed to atmosphere. | 09-30-2010 |
Jirun Sun, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20120172485 | DENTAL COMPOSITIONS WITH TITANIUM DIOXIDE NANOPARTICLES - A polymeric composition comprising modified-TiO | 07-05-2012 |
20150257986 | ENZYMATICALLY AND HYDROLYTICALLY STABLE RESINS, RESIN MONOMERS, AND RESIN COMPOSITES FOR USE IN DENTAL PREVENTIVE AND RESTORATIVE APPLICATIONS - A composition of matter includes one or more functionalized vinylbenzyl components of the formula | 09-17-2015 |
Kunshan Sun, Greenbelt, MD US
Patent application number | Description | Published |
---|---|---|
20090139937 | Polymers for Use in Centrifugal Separation of Liquids - Contemplated compositions and methods allow for in-situ formation of a rigid seal layer in a blood collection tube between a cell-depleted phase and a cell-enriched phase. Preferably, the seal layer is formed upon brief UV irradiation and comprises an acrylate, a methacrylate, an epoxy, a urethane, and/or a thiol-ene polymer. | 06-04-2009 |
20150139868 | Polymers For Use In Centrifugal Separation Of Liquids - Contemplated compositions and methods allow for in-situ formation of a rigid seal layer in a blood collection tube between a cell-depleted phase and a cell-enriched phase. Preferably, the seal layer is formed upon brief UV irradiation and comprises an acrylate, a methacrylate, an epoxy, a urethane, and/or a thiol-ene polymer. | 05-21-2015 |
Lewis Sun, Linthicum, MD US
Patent application number | Description | Published |
---|---|---|
20100095348 | SYSTEM AND METHOD FOR MANAGEMENT AND TRANSLATION OF TECHNICAL SECURITY POLICIES AND CONFIGURATIONS - A system and method translating information of a source policy configuration into a universal data type useable with a target policy configuration. The disclosed system and method provide comprehensive and highly automated translation of security policies and configurations into a normalized format, thereby enabling management and transformation of information across various types of technologies. Normalized data format is utilized to output data into different formats or data types. | 04-15-2010 |
Limin Sun, Germantown, MD US
Patent application number | Description | Published |
---|---|---|
20090035378 | NANOSTRUCTURED BIOACTIVE MATERIALS PREPARED BY DUAL NOZZLE SPRAY DRYING TECHNIQUES - Nano-particles of calcium and phosphorous compounds are made in a highly pure generally amorphous state by spray drying a weak acid solution of said compound and evaporating the liquid from the atomized spray in a heated column followed by collection of the precipitated particles. Hydroxyapatite (HA) particles formed by such apparatus and methods are examples of particle manufacture useful in bone and dental therapies. Dual nozzle spraying techniques are utilized for generally insoluble compounds. | 02-05-2009 |
20090093566 | Dental releasing materials - Combining nanosized particles of a source of desired dental restorative, repair or therapeutic materials with strengthening agents in various generally nanosized form such as whiskers, fibers, particles and the like in a resin matrix provides a highly strain resistant composite which more effectively releases the therapeutic agents. The utilization of nano sized particles of the therapeutic agent in the combination enables observation of significantly improved therapeutic results. | 04-09-2009 |
20120217665 | Method for Preparation of Well-Dispersed, Discrete Nanoparticles by Spray Drying Techniques - A method for preparing uniquely sized nanoparticles of CaF | 08-30-2012 |
Miao-Kun Sun, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20090036514 | Therapeutic effects of Bryostatins, Bryologs, and other related substances on Ischemia/stroke-induced memory impairment and brain injury - The invention provides for the use of protein kinase activators or boosters of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) or other neurotrophic factors to treat stroke. Specifically, the present invention provides methods of treating stroke comprising the steps of identifying a subject having suffered a stroke and administering to said subject an amount of a pharmaceutical composition comprising a protein kinase C (PKC) activator or 4-methylcatechol acetic acid (MCBA) and a pharmaceutically acceptable carrier effective to treat at least one symptom of stroke. | 02-05-2009 |
20090041667 | Treatment of Depressive Disorders - The invention provides for the use of carbonic anhydrase activators; protein kinase C activators and FGF-18 to treat depressive disorders. The invention also relates to improved animal models and methods for screening and identifying compounds the treatment of depressive disorders. | 02-12-2009 |
20110288022 | TREATMENT OF DEPRESSIVE DISORDERS - The invention provides for the use of carbonic anhydrase activators; protein kinase C activators and FGF-18 to treat depressive disorders. The invention also relates to improved animal models and methods for screening and identifying compounds the treatment of depressive disorders. | 11-24-2011 |
20130165375 | TREATMENT OF DEPRESSIVE DISORDERS - The invention provides for the use of carbonic anhydrase activators; protein kinase C activators and FGF-18 to treat depressive disorders. The invention also relates to improved animal models and methods for screening and identifying compounds to treat depressive disorders. | 06-27-2013 |
20130165453 | THERAPEUTIC EFFECTS OF BRYOSTATINS, BRYOLOGS, AND OTHER RELATED SUBSTANCES ON ISCHEMIA/STROKE-INDUCED MEMORY IMPAIRMENT AND BRAIN INJURY - The invention provides for the use of protein kinase activators or boosters of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) or other neurotrophic factors to treat stroke. Specifically, the present invention provides methods of treating stroke comprising the steps of identifying a subject having suffered a stroke and administering to said subject an amount of a pharmaceutical composition comprising a protein kinase C (PKC) activator or 4-methylcatechol acetic acid (MCBA) and a pharmaceutically acceptable carrier effective to treat at least one symptom of stroke. | 06-27-2013 |
20130331444 | TREATMENT OF COGNITIVE DISORDERS ASSOCIATED WITH ABNORMAL DENDRITIC SPINES USING PKC ACTIVATORS - The present disclosure provides methods of treating a cognitive disorder associated with abnormal dendritic spines, such as Fragile X Syndrome, Fragile X Associated Tremor/Ataxia Syndrome, autism, or mental retardation, using PKC activators. | 12-12-2013 |
Ming-Hao Sun, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20090002176 | Backscatter Limited Tags - Methods and apparatuses for secure communications of confidential information are provided. In an embodiment, a method of communicating with a population of radio frequency identification tags includes transmitting a first interrogation signal, receiving a response to the first interrogation signal from at least one RFID tag at a first received signal strength including at least a portion of a first identification code, and transmitting a second interrogation signal that includes a request for confidential information, a command to transmit a response to the second interrogation signal at a secure power level, and the first identification code. In another embodiment, a method for communicating with an RFID tag includes receiving an interrogation signal that includes a request for confidential information and transmitting a response to the interrogation signal at a secure power level. The response includes the confidential information. | 01-01-2009 |
Nuo Sun, Bethesda, MD US
Patent application number | Description | Published |
---|---|---|
20160038477 | ANTIFUNGAL DRUGS - The present invention relates to the administration of compounds of formula (I) for the treatment and/or prevention of fungal infections in subjects in need thereof. The methods of the invention also relates to the administration of pharmaceutical compositions comprising compounds of formula (I) for the treatment and/or prevention of fungal infections in subjects in need thereof. Subjects suffering from fungal infection and immunocompromised subjects may particularly benefit from the methods and compositions of the invention. | 02-11-2016 |
Peter Daopin Sun, Derwood, MD US
Patent application number | Description | Published |
---|---|---|
20110165623 | Compositions and Methods for the High Efficiency Expression of the Transforming Growth Factor-Beta Supergene Family - Novel compositions and methods for the high efficiency production of the transforming growth factor-beta (TGFβ) supergene family of peptide growth factors are provided. | 07-07-2011 |
Roaggai Sun, Ellicott City, MD US
Patent application number | Description | Published |
---|---|---|
20110117133 | Novel Recombinant BCG Tuberculosis Vaccine Designed to Elicit Immune Responses to Mycobacterium Tuberculosis in all Physiological Stages of Infection and Disease - A vaccine against | 05-19-2011 |
Ronggai Sun, Ellicott City, MD US
Patent application number | Description | Published |
---|---|---|
20080286852 | Electroporation of Mycobacterium and Overexpression of Antigens in Mycobacteria - Recombinant | 11-20-2008 |
20090136534 | NOVEL RECOMBINANT BCG TUBERCULOSIS VACCINE DESIGNED TO ELICIT IMMUNE RESPONSES TO MYCOBACTERIUM TUBERCULOSIS IN ALL PHYSIOLOGICAL STAGES OF INFECTION AND DISEASE - A vaccine against | 05-28-2009 |
20100047286 | Recombinant BCG strains with enhanced ability to escape the endosome - strains that have an enhanced ability to elicit a Histocompatibility-Class I-restricted CD8 | 02-25-2010 |
20100233213 | Recombinant BCG Strains with Enhanced Ability to Escape the Endosome - strains that have an enhanced ability to elicit a MHC-Class I-restricted CD8 | 09-16-2010 |
Sean X. Sun, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20100253328 | MAGNETIC TWEEZERS METHOD TO MEASURE SINGLE MOLECULE TORQUE - A system and a method for determining the torque imposed on a filament, such as a single DNA strand or macromolecule, using a magnetic probe and an imaging device. | 10-07-2010 |
Shisheng Sun, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20150233903 | SOLID PHASE GLYCAN AND GLYCOPEPTIDE ANALYSIS AND MICROFLUIDIC CHIP FOR GLYCOMIC EXTRACTION, ANALYSIS AND METHODS FOR USING SAME - Highly specific and novel solid phase methods for analyzing glycans and proteoglycans using a solid phase system are provided. The present invention also provides an integrated apparatus and methods of use which comprises a high-throughput glycan isolation and reverse-phase liquid chromatography (RPLC) for on-chip glycan extraction, modification and separation. The coverage of detected N-glycans by the GIG-chip-LC apparatus of the present invention can be significantly improved, especially for the low abundant species. Chip-LC by PGC minimizes dynamic range of glycan concentrations in fractions, resulting in detection of low-abundance glycans. Glycan isomers were able to be separated by the chip-LC portion of the apparatus. The GIG-chip-LC apparatus of the present invention can be used to analyze glycans from tissue and sera samples, thus providing a reliable tool for glycomic analysis. The reproducible performance and ability to detect unique glycans from tissue samples provides a powerful means for discovery of abnormal glycans associated with disease states. | 08-20-2015 |
Wellington Sun, Kensington, MD US
Patent application number | Description | Published |
---|---|---|
20140271714 | INDUCTION OF AN IMMUNE RESPONSE AGAINST DENGUE VIRUS USING THE PRIME-BOOST APPROACH - The invention relates to methods for the induction of an immune response to dengue virus. The method of inducing an immune response against dengue virus comprises administration of a non-replicating immunogen followed by a boost with a tetravalent live attenuated viral vaccine. Another aspect of the inventive subject matter is a method of inducing an immune response against dengue virus using a heterologous prime-boost regimen with the priming immunogen comprising a DNA expression system, an adenovirus expression vector or a Venezuelan equine encephalitis virus replicon system and the boosting immunogen comprising the same without the DNA expression system. Each expression system contains DNA sequences encoding dengue viral proteins. | 09-18-2014 |
Xiaoli Sun, Clarksville, MD US
Patent application number | Description | Published |
---|---|---|
20100027602 | TIME DELAY AND DISTANCE MEASUREMENT - A method for measuring time delay and distance may include providing an electromagnetic radiation carrier frequency and modulating one or more of amplitude, phase, frequency, polarization, and pointing angle of the carrier frequency with a return to zero (RZ) pseudo random noise (PN) code. The RZ PN code may have a constant bit period and a pulse duration that is less than the bit period. A receiver may detect the electromagnetic radiation and calculate the scattering profile versus time (or range) by computing a cross correlation function between the recorded received signal and a three-state RZ PN code kernel in the receiver. The method also may be used for pulse delay time (i.e., PPM) communications. | 02-04-2010 |
Yao Sun, Montgomery Village, MD US
Patent application number | Description | Published |
---|---|---|
20080236033 | Slow-release floating fertilizer - Floating slow-release fertilizer is designed to significantly reduce carbon dioxide in the atmosphere. This granulated fertilizer has a density lighter than seawater. Therefore its pellets can float on the surface of seawater. After being dispensed into water, the pellets are able to continually release certain nutrients for a period of time. During this period, an otherwise inanimate water region is temporarily suitable for plant growth. Floating slow-release fertilizer enables the growth of planting phytoplankton in ocean to remove CO | 10-02-2008 |
Yichun Sun, North Potomac, MD US
Patent application number | Description | Published |
---|---|---|
20100099696 | Tamper resistant oral dosage forms containing an embolizing agent - Oral dosage form containing a therapeutically effective amount of a drug susceptible to abuse and an effective amount of an embolizing agent which causes the production of a solid or semi-solid embolus or blockage after tampering. | 04-22-2010 |
20130224265 | Dosage Forms for Tamper Prone Therapeutic Agents - A dosage form from which a burst release of a drug contained within a tampered dosage form is reduced or retarded by the presence in or on the dosage form of a TPTA (Tamper Prone Therapeutic Agent) trap. If the dosage form has not been tampered with, the TPTA trap does not significantly interfere with the rate of release of the drug from the dosage form. However, if the dosage form has been physically tampered with, the TPTA trap reduces or retards burst release of the drug from the dosage form. | 08-29-2013 |
Yichun Sun, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20080300322 | Delivery vehicles containing rosin resins - Compositions containing a vehicle containing a rosin resin or derivative and a non-volatilized solvent or plasticizer. The compositions may be used to deliver a biologically active substance such as an active pharmaceutical ingredient. The concentration of rosin resin or derivative in the vehicle is sufficient to alter the release rate from the composition of a biologically active substance that is dissolved, dispersed, emulsified, or suspended in the vehicle. | 12-04-2008 |
20090239891 | Sustained Release Dosage Forms of Analgesic Medications - Parenteral extravascular administration of a composition containing an analgesic medication of low water solubility that is dissolved, suspended, or emulsified in a solvent system results in the deposition of the analgesic medication at the site of administration and provides a controlled release of the analgesic medication from the site and a prolonged analgesia that may persist for several days following administration. | 09-24-2009 |
Yishen Sun, Clarksburg, MD US
Patent application number | Description | Published |
---|---|---|
20160065439 | System and Method for Information Delivery with Multiple Point Transmission - A system and method for information delivery with multiple point transmission are provided. A method for detecting lost packets is provided. The method includes initiating a timer for a received packet at a receiving transmission point, where the timer is set according to a time value associated with the received packet. The method also includes determining that a delivery of the received packet has failed according to the timer elapsing, and transmitting a lost packet report to a primary transmission point that distributed the received packet to the receiving transmission point. | 03-03-2016 |
Yuze Sun, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20140017700 | SENSITIVE INTRACAVITY BIOSENSING PLATFORM AND METHODS FOR DETECTION THEREWITH - The present disclosure provides a method of detecting a target analyte, by binding the target analyte and a probe with at least one fluorophore to form a fluid composition. The fluid composition is excited within a laser cavity. The method comprises measuring a laser emission from the fluid composition based on an interaction between the target analyte and the probe. In certain aspects, the method provides hybridizing the target analyte and the probe, prior to the exciting. In certain variations, the methods comprise detecting a target analyte by measuring a laser emission from the fluid composition based on an interaction between the target analyte, where the interaction is probe energy transfer, intercalation, hybridization of the target analyte and the probe, or combinations thereof. The energy transfer can include fluorescence resonance energy transfer (FRET), FRET with a molecular-beacon, or cavity-assisted radiative energy transfer, by way of non-limiting example. | 01-16-2014 |
Zairen Sun, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20120231969 | PROTEIN ARRAYS AND USES THEREOF - Illustrative embodiments herein disclosed relate to protein arrays, methods for making the arrays and methods for using them, among others. In some embodiments known proteins representing at least 50% of the loci in the human genome are arrayed in known positions on a support. In some embodiments arrays are made of proteins purified from cell lysates by affinity binding to the support. In some embodiments protein arrays are used to decode the binding specificity of antibodies. In some embodiments protein arrays are used to diagnose auto-immune disorders. Many other embodiments and general features are disclosed. | 09-13-2012 |
Zhaoli Sun, Perry Hall, MD US
Patent application number | Description | Published |
---|---|---|
20120171716 | Measurement of Mitochondrial Membrane Potential to Assess Organ Dysfunction - The present invention relates to the field of organ transplantation. More specifically, the present invention provides methods for predicting organ function after transplantation. In certain embodiments, the method comprises measuring mitochondrial membrane potential from a biopsy sample from the donor organ. The present invention is also applicable to organ dysfunction in general. More specifically, the methods of the present invention may be useful in formulating prognoses for patients with acute or chronic organ dysfunction due to ischemia, infection, drug injury or age. In this rapid procedure, only small samples of tissue are required, enabling the clinical application of mitochondrial function previously thought impractical. | 07-05-2012 |
20130338183 | COMPOSITIONS AND METHODS FOR MOBILIZING STEM CELLS - The present invention relates to the field of hematopoietic stem cells. More specifically, the present invention provides methods and composition useful for peripheral blood stem cell mobilization. In one embodiment, a method of treating an organ transplant recipient comprises administering to the recipient a low dose of Tacrolimus in an amount sufficient to mobilize stem cells to the peripheral blood of the recipient. In a specific embodiment, the low dose of Tacrolimus is in the range of about 0.05 mg/kg to about 0.5 mg/kg. | 12-19-2013 |